Triple

T33205448
Position Surface form Disambiguated ID Type / Status
Subject tumor necrosis factor alpha E850005 entity
Predicate cleavedBy P176187 FINISHED
Object TACE
TACE (TNF-α converting enzyme), also known as ADAM17, is a membrane-bound metalloprotease that regulates inflammation and cell signaling by shedding various cell-surface proteins, including pro–tumor necrosis factor alpha.
E2042581 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: TACE | Statement: [tumor necrosis factor alpha, cleavedBy, TACE]
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: TACE
Triple: [tumor necrosis factor alpha, cleavedBy, TACE]
Generated description
TACE (TNF-α converting enzyme), also known as ADAM17, is a membrane-bound metalloprotease that regulates inflammation and cell signaling by shedding various cell-surface proteins, including pro–tumor necrosis factor alpha.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: cleavedBy
Context triple: [tumor necrosis factor alpha, cleavedBy, TACE]
  • A. cleavagePattern
    Indicates the characteristic way in which something splits, divides, or separates into parts under specific conditions.
  • B. cleavageOrientation
    Indicates the directional alignment or pattern along which a material or object tends to split or cleave.
  • C. canBeDissectedBy
    Indicates that one entity is capable of being divided or analyzed into parts by another entity or method.
  • D. clearedOf
    Indicates that an entity has been officially found not responsible for, or freed from suspicion of, a previously alleged wrongdoing, charge, or negative condition.
  • E. cleared
    Indicates that an entity has removed obstacles, doubts, or restrictions from another entity or from a particular state or situation.
  • F. None of above. chosen

Provenance (7 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69f3495efedc8190843a5728089544b9 completed April 30, 2026, 12:21 p.m.
NER Named-entity recognition batch_69f6dd3cc0648190a275812d6711275a completed May 3, 2026, 5:29 a.m.
NED1 Entity disambiguation (via context triple) batch_6a352fc40600819092779618431f0ec2 completed June 19, 2026, 12:02 p.m.
NEDg Description generation batch_6a353033d4808190b4d8096162a14557 completed June 19, 2026, 12:04 p.m.
NED2 Entity disambiguation (via description) batch_6a353298f99c8190a2774b4aab087295 completed June 19, 2026, 12:14 p.m.
PD Predicate disambiguation batch_69f6d82eaee081908f06a71546315aea completed May 3, 2026, 5:07 a.m.
PDg Predicate description generation batch_69f6dd3b335481909e24d4eb5b0269f9 completed May 3, 2026, 5:29 a.m.
Created at: May 1, 2026, 1:30 a.m.